Fielmann Aktiengesellschaft (FIE.DE)
EUR 52.5
(5.0%)
EUR 52.5
(5.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 652.37 Million EUR | 29.01% |
| 2022 | 505.65 Million EUR | 10.34% |
| 2021 | 458.25 Million EUR | 7.64% |
| 2020 | 425.72 Million EUR | 14.2% |
| 2019 | 372.79 Million EUR | 30085.43% |
| 2018 | 1.23 Million EUR | -20.58% |
| 2017 | 1.55 Million EUR | 18.7% |
| 2016 | 1.31 Million EUR | 37.89% |
| 2015 | 950 Thousand EUR | -19.22% |
| 2014 | 1.17 Million EUR | 19.76% |
| 2013 | 982 Thousand EUR | -20.1% |
| 2012 | 1.22 Million EUR | -71.35% |
| 2011 | 4.29 Million EUR | 0.0% |
| 2010 | - EUR | -100.0% |
| 2009 | 45.53 Million EUR | 522.89% |
| 2008 | 7.31 Million EUR | 0.0% |
| 2007 | - EUR | 0.0% |
| 2006 | - EUR | 0.0% |
| 2005 | - EUR | 0.0% |
| 2004 | - EUR | 0.0% |
| 2003 | - EUR | 0.0% |
| 2002 | - EUR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 518.9 Million EUR | 0.0% |
| 2024 Q1 | - EUR | -100.0% |
| 2023 Q1 | 473.19 Million EUR | -6.42% |
| 2023 Q3 | - EUR | -100.0% |
| 2023 Q2 | 462.22 Million EUR | -2.32% |
| 2023 Q4 | 592.14 Million EUR | 0.0% |
| 2023 FY | 652.37 Million EUR | 29.01% |
| 2022 Q2 | 460.4 Million EUR | 0.98% |
| 2022 Q1 | 455.94 Million EUR | -0.51% |
| 2022 Q3 | 460.01 Million EUR | -0.09% |
| 2022 FY | 505.65 Million EUR | 10.34% |
| 2022 Q4 | 505.65 Million EUR | 9.92% |
| 2021 Q1 | 424.91 Million EUR | -0.19% |
| 2021 Q3 | 450.76 Million EUR | 5.1% |
| 2021 Q4 | 458.25 Million EUR | 1.66% |
| 2021 FY | 458.25 Million EUR | 7.64% |
| 2021 Q2 | 428.9 Million EUR | 0.94% |
| 2020 Q3 | 348.38 Million EUR | -1.38% |
| 2020 FY | 425.72 Million EUR | 14.2% |
| 2020 Q4 | 425.72 Million EUR | 22.2% |
| 2020 Q2 | 353.25 Million EUR | -3.75% |
| 2020 Q1 | 367.03 Million EUR | -1.54% |
| 2019 Q4 | 372.79 Million EUR | -2.46% |
| 2019 Q3 | 382.18 Million EUR | 0.44% |
| 2019 Q2 | 380.49 Million EUR | 0.2% |
| 2019 FY | 372.79 Million EUR | 30085.43% |
| 2019 Q1 | 379.72 Million EUR | 30646.64% |
| 2018 Q3 | 716 Thousand EUR | -49.44% |
| 2018 Q1 | 1.5 Million EUR | -2.96% |
| 2018 FY | 1.23 Million EUR | -20.58% |
| 2018 Q2 | 1.41 Million EUR | -6.16% |
| 2018 Q4 | 1.23 Million EUR | 72.49% |
| 2017 FY | 1.55 Million EUR | 18.7% |
| 2017 Q4 | 1.55 Million EUR | -34.08% |
| 2017 Q3 | 2.35 Million EUR | 10.65% |
| 2017 Q2 | 2.13 Million EUR | 12.92% |
| 2017 Q1 | 1.88 Million EUR | 44.12% |
| 2016 Q2 | 1.54 Million EUR | -14.19% |
| 2016 FY | 1.31 Million EUR | 37.89% |
| 2016 Q4 | 1.31 Million EUR | -8.01% |
| 2016 Q3 | 1.42 Million EUR | -7.65% |
| 2016 Q1 | 1.79 Million EUR | 89.16% |
| 2015 FY | 950 Thousand EUR | -19.22% |
| 2015 Q1 | 2.13 Million EUR | 81.8% |
| 2015 Q4 | 950 Thousand EUR | -54.04% |
| 2015 Q3 | 2.06 Million EUR | -4.53% |
| 2015 Q2 | 2.16 Million EUR | 1.26% |
| 2014 Q2 | 2.36 Million EUR | 1.37% |
| 2014 Q1 | 2.32 Million EUR | 137.07% |
| 2014 FY | 1.17 Million EUR | 19.76% |
| 2014 Q4 | 1.17 Million EUR | -43.79% |
| 2014 Q3 | 2.09 Million EUR | -11.36% |
| 2013 Q1 | 2.58 Million EUR | 110.01% |
| 2013 FY | 982 Thousand EUR | -20.1% |
| 2013 Q4 | 982 Thousand EUR | -61.95% |
| 2013 Q3 | 2.58 Million EUR | -12.09% |
| 2013 Q2 | 2.93 Million EUR | 13.75% |
| 2012 Q4 | 1.22 Million EUR | 0.0% |
| 2012 Q3 | - EUR | 0.0% |
| 2012 Q2 | - EUR | 0.0% |
| 2012 Q1 | - EUR | -100.0% |
| 2012 FY | 1.22 Million EUR | -71.35% |
| 2011 Q3 | - EUR | 0.0% |
| 2011 Q1 | - EUR | -100.0% |
| 2011 Q2 | - EUR | 0.0% |
| 2011 Q4 | 4.29 Million EUR | 0.0% |
| 2011 FY | 4.29 Million EUR | 0.0% |
| 2010 Q3 | - EUR | 0.0% |
| 2010 FY | - EUR | -100.0% |
| 2010 Q4 | 4.98 Million EUR | 0.0% |
| 2010 Q1 | - EUR | -100.0% |
| 2010 Q2 | - EUR | 0.0% |
| 2009 FY | 45.53 Million EUR | 522.89% |
| 2009 Q4 | 45.53 Million EUR | 0.0% |
| 2008 FY | 7.31 Million EUR | 0.0% |
| 2007 FY | - EUR | 0.0% |
| 2006 FY | - EUR | 0.0% |
| 2005 FY | - EUR | 0.0% |
| 2004 FY | - EUR | 0.0% |
| 2003 FY | - EUR | 0.0% |
| 2002 FY | - EUR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| SCHOTT Pharma AG & Co. KGaA | 72.33 Million EUR | -801.924% |
| Carl Zeiss Meditec AG | 155.69 Million EUR | -319.003% |
| Gerresheimer AG | 1.04 Billion EUR | 37.351% |
| Sartorius Aktiengesellschaft | 5.31 Billion EUR | 87.717% |
| Sartorius Aktiengesellschaft | 5.31 Billion EUR | 87.717% |